Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mace

Showing results (171-180 of 190) with videos related to

Pageof 19
Sort By:
JCSM Rapid Communications|September 13, 2021
Murine cancer cachexia models replicate elevated catabolic pembrolizumab clearance in humansAlyssa Marie M Castillo, Trang T Vu, Sophia G Liva, et al.
Frontiers in Immunology|April 16, 2026
Fc gamma receptor binding modulates IgG clearance in cancer cachexiaBryan C Remaily, Kyeongmin Kim, Justin Thomas, et al.
Cancer Immunology, Immunotherapy : CII|April 15, 2024
CD200 is overexpressed in the pancreatic tumor microenvironment and predictive of overall survivalJessica Wedig, Shrina Jasani, Debasmita Mukherjee, et al.
Pharmacological Research|December 25, 2023
Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexiaTrang T Vu, Kyeongmin Kim, Millennium Manna, et al.
International Immunopharmacology|May 8, 2026
FcRn function alone cannot account for elevated IgG clearance in the Lewis lung carcinoma model of cancer cachexiaAdeoluwa Adeluola, Justin Thomas, Bryan Remaily, et al.
Cancer Research|March 3, 2017
Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor MicroenvironmentSobeyda B Gomez-Chou, Agnieszka Katarzyna Swidnicka-Siergiejko, Niharika Badi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2018
Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell FunctionAndrew Stiff, Prashant Trikha, Bethany Mundy-Bosse, et al.
International Journal of Molecular Sciences|July 9, 2022
The Neonatal Fc Receptor Is Elevated in Monocyte-Derived Immune Cells in Pancreatic CancerJustin Thomas, Molly A Torok, Kriti Agrawal, et al.
JCI Insight|March 7, 2023
Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell- and CXCR3-dependent mannerMichael Brandon Ware, Maggie Phillips, Christopher McQuinn, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2016
Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic AdenocarcinomaAnne M Noonan, Matthew R Farren, Susan M Geyer, et al.
Pageof 19

Showing results (171-180 of 190) with videos related to

Sort By:
Pageof 19
JCSM Rapid Communications|September 13, 2021
Murine cancer cachexia models replicate elevated catabolic pembrolizumab clearance in humansAlyssa Marie M Castillo, Trang T Vu, Sophia G Liva, et al.
Frontiers in Immunology|April 16, 2026
Fc gamma receptor binding modulates IgG clearance in cancer cachexiaBryan C Remaily, Kyeongmin Kim, Justin Thomas, et al.
Cancer Immunology, Immunotherapy : CII|April 15, 2024
CD200 is overexpressed in the pancreatic tumor microenvironment and predictive of overall survivalJessica Wedig, Shrina Jasani, Debasmita Mukherjee, et al.
Pharmacological Research|December 25, 2023
Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexiaTrang T Vu, Kyeongmin Kim, Millennium Manna, et al.
International Immunopharmacology|May 8, 2026
FcRn function alone cannot account for elevated IgG clearance in the Lewis lung carcinoma model of cancer cachexiaAdeoluwa Adeluola, Justin Thomas, Bryan Remaily, et al.
Cancer Research|March 3, 2017
Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor MicroenvironmentSobeyda B Gomez-Chou, Agnieszka Katarzyna Swidnicka-Siergiejko, Niharika Badi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2018
Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell FunctionAndrew Stiff, Prashant Trikha, Bethany Mundy-Bosse, et al.
International Journal of Molecular Sciences|July 9, 2022
The Neonatal Fc Receptor Is Elevated in Monocyte-Derived Immune Cells in Pancreatic CancerJustin Thomas, Molly A Torok, Kriti Agrawal, et al.
JCI Insight|March 7, 2023
Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell- and CXCR3-dependent mannerMichael Brandon Ware, Maggie Phillips, Christopher McQuinn, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2016
Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic AdenocarcinomaAnne M Noonan, Matthew R Farren, Susan M Geyer, et al.
Pageof 19